The C-peptide response to a standard mixed meal in a group of Brazilian type 1 diabetic patients

Brazilian Journal of Medical and Biological Research

Volumn 30, Issue 10, 1997, Pages 1169-1174

  Pozzan, R ^a,b   Dimetz, T ^a   Gazzola, H M ^a   Gomes, M B ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BRAZIL; CHILD; EATING; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE;

ADOLESCENT; ADULT; BRAZIL; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; EATING; FEMALE; HUMANS; MALE;

EID: 0031242683     PISSN: 0100879X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0100-879X1997001000005     Document Type: Article

References (23)

1. Assan R, Feutren G, Sirmai J, Lebsiene C, Boitard C, Vexian P, Du Rostu H, Rodier M, Figoni M, Vague P, Hors J & Bach J-F (1990). Plasma C-peptide levels and clinical remissions in recent onset type I diabetic patients treated with cyclosporin A and insulin. Diabetes, 39: 768-774.
2. Clarson C, Daneman D, Drash AL, Becker DJ & Ehrlich RM (1987). Residual B-cell function in children with IDDM: reproducibility of testing and factors influencing insulin secretory reserve. Diabetes Care, 10: 33-38.
3. Faber OK & Binder C (1977). C-peptide response to glucagon: a test for the residual B-cell function in diabetes mellitus. Diabetes, 26: 605-610.
4. Schiffrin A, Suissa S, Witzner G, Poussier P & Lalla D (1992). Factor predicting course of β-cell function in IDDM. Diabetes Care, 15: 997-1001.
5. Snorgaard O, Lassen LH & Binder C (1992). Homogeneity in pattern of decline of B-cell function in IDDM - prospective study of 204 consecutive cases followed for 74 years. Diabetes Care, 15: 1009-1013.
6. Dahlquist G, Blom L, Bolme P, Hagenfeldt L, Lindgren F, Persson B, Thalme B, Theorell M & Westin S (1982). Metabolic control in 131 juvenile-onset diabetic patients as measured by Hb A1C: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections. Diabetes Care, 5: 399-403.
7. Ludvigsson J & Heding LG (1976). C-peptide in children with juvenile diabetes. Diabetologia, 12: 627-630.
8. Mirel RD, Ginsberg-Feltner F, Horwitz DL & Rayfield EJ (1980). C-peptide reserve in insulin-dependent diabetes: comparative responses to glucose, glucagon and tolbutamide. Diabetologia, 19: 183-188.
9. Garcia-Webb P (1982) Correlation between fasting serum C-peptide and β-cell insulin secretory capacity in diabetes mellitus. Diabetologia, 22: 296.
10. Gjessing HJ, Matzen LE, Fraland A & Faber OK (1987). Correlation between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics. Diabetes Care, 10: 487-490.
11. The DCCT Research Group (1987). Effects of age, duration and treatment of insulin dependent diabetes mellitus on residual B-cell function: observations during eligibility testing for the diabetes control and complications trial (DCCT). Journal of Clinical Endocrinology and Metabolism, 65: 30-36.
12. Wallesteen M, Dahlquist G, Persson B, Landin-Olsson M, Lernmark A, Sundkuist G & Thalme B (1988). Factors influencing the magnitude duration and rate of fall of B-cell function in type I (insulin-dependent) diabetic children followed for two years from their clinical diagnosis. Diabetologia, 31: 664-669.
13. Sochett E, Daneman D, Clarson C & Ehrlich RM (1987). Factors affecting and patterns of residual insulin secretion during the first year of type I (insulin dependent) diabetes mellitus in children. Diabetologia, 30: 453-459.
14. Rjasanowski I, Michaelis D, Keilacker H, Besch W, Richter KV & Heinke P (1987). 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control. Experimental and Clinical Endocrinology, 89: 216-224.
15. Fukuda M, Tanaka A, Tahara Y, Ikegami H, Yamamoto Y, Kumahara Y & Shima K (1988). Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control. Diabetes, 37: 81-88.
16. Sberna P, Valentini V, Cimino A, Sabathi MC, Rotondi A, Crisetig M & Spandrio S (1986). Residual β-cell function in insulin-dependent (type I) diabetics with and without retinopathy. Acta Diabetologica Latina, 23: 339-344.
17. Hsieh SD, Kanazawa Y & Akanuma Y (1985). Serum free C-peptide response to oral glucose loading as a parameter for the monitoring of pancreatic B-cell function in diabetic patients. Diabetes Research and Clinical Practice, 1: 109-114.
18. Le Floch JP, Escuyer P, Boudin E, Baudon D & Perlemuter L (1990). Blood glucose area under the curve. Methodological aspects. Diabetes Care, 13: 172-175.
19. National Diabetes Data Group (1979). Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes, 28: 1039-1057.
20. Siegel S (1975). Estatistica nāo Paramétrica. 1st edn. McGraw-Hill, Sāo Paulo.
21. Keilacker H, Kohnert K-D & Ziegler M (1990). Influence of polyethylene glycol (PEG) extraction on the C-peptide determination in sera from insulin-dependent diabetic patients with circulating insulin antibodies. Experimental and Clinical Endocrinology, 95: 119-122.
22. Hendriksen C. Faber OK, Dreger J & Binder C (1977). Prevalence of residual β cell function in insulin-treated diabetics evaluated by plasma C-peptide response to intravenous glucagon. Diabetologia, 13: 615-619.
23. Faber OK & Binder C (1977). B-cell function and blood glucose control in insulin dependent diabetics within the first month of insulin treatment. Diabetologia, 13: 263-268.